Financial statements Phoenix Pharma Polska
Balance sheet data of PHOENIX PHARMA POLSKA
Year
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|---|---|---|---|---|
Total assets | 77 104 652,71 | 80 459 329,42 | 75 316 389,11 | 71 555 277,51 | 78 849 845,86 |
A. Fixed assets | 10 964 420,42 | 10 955 791,07 | 9 434 435,28 | 8 433 025,69 | 7 746 773,97 |
B. Current assets | 66 140 232,29 | 69 503 538,35 | 65 881 953,83 | 63 122 251,82 | 71 103 071,89 |
C. Share capital contributions (basic funds) | - | - | - | - | - |
D. Own shares (stocks) | - | - | - | - | - |
Total liabilities | 77 104 652,71 | 80 459 329,42 | 75 316 389,11 | 71 555 277,51 | 78 849 845,86 |
A. Equity | 48 247 198,33 | 49 467 583,91 | 50 757 564,85 | 32 695 141,88 | 35 685 324,46 |
B. Liabilities and provisions for liabilities | 28 857 454,38 | 30 991 745,51 | 24 558 824,26 | 38 860 135,63 | 43 164 521,40 |
I. Long-term liabilities | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
II. Short-term liabilities | 28 348 756,10 | 30 027 354,33 | 23 721 992,39 | 37 752 932,64 | 41 790 671,46 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.